Proposed EU HTA Methods Pose Challenges For Cancer Therapies, Warns EFPIA

Proposed methods for conducting EU-level joint clinical assessments could result in such a broad range of comparator therapies that companies are unable to fulfill scoping requirements, according to a report commissioned by industry federation EFPIA.